Discontinued — last reported Q4 '24
McKesson International — Total operating profit (loss) increased by 121.9% to $111.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 11.9%, from $126.00M to $111.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved margins, better cost management, or higher sales volume in international markets, while a decrease points to margin compression or operational inefficiencies.
This metric measures the total earnings generated by the International segment after deducting all operating expenses, i...
This is a standard segment reporting metric across the pharmaceutical wholesale industry, allowing for direct comparison of regional operating margins against competitors with similar international footprints.
mck_segment_international_1_total_operating_profit_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.00M | -$146.00M | -$668.00M | -$6.00M | -$37.00M | $136.00M | $57.00M | $66.00M | $126.00M | $90.00M | -$508.00M | $111.00M |
| QoQ Change | — | -375.5% | -357.5% | +99.1% | -516.7% | +467.6% | -58.1% | +15.8% | +90.9% | -28.6% | -664.4% | +121.9% |
| YoY Change | — | — | — | -111.3% | +74.7% | +120.4% | >999% | +278.4% | -7.4% | +57.9% | -869.7% | -11.9% |